SEIDENBERG BETH C 4
4 · Vera Therapeutics, Inc. · Filed Oct 30, 2024
Insider Transaction Report
Form 4
SEIDENBERG BETH C
Director
Transactions
- Sale
Class A Common Stock
2024-10-28$48.01/sh−14,798$710,486→ 131,755 total - Sale
Class A Common Stock
2024-10-28$49.54/sh−202$10,007→ 131,553 total
Holdings
- 4,012(indirect: See Footnote)
Class A Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 19, 2024.
- [F2]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $48.00 to $48.30, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $49.50 to $49.70, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]Shares are held by the Samuel B. Seidenberg Irrevocable Trust, established on July 1, 2013, for which the Reporting Person and her spouse serve as trustees.